Protective effect of sacubitril valsartan combined with metoprolol on heart function in treatment of coronary atherosclerotic heart disease with chronic heart failure

ZHANG Xia, LI Zhengzhang, XU Ying, LI Hui

PDF(1552 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1552 KB)
World Clinical Drug ›› 2022, Vol. 43 ›› Issue (11) : 1462-1469. DOI: 10.13683/j.wph.2022.11.013
Article

Protective effect of sacubitril valsartan combined with metoprolol on heart function in treatment of coronary atherosclerotic heart disease with chronic heart failure

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 43(11): 1462-1469 https://doi.org/10.13683/j.wph.2022.11.013

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1552 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉